PharmaShots | Incisive News in 3 Shots

Subscribe Now

Eosinophilic Asthma

GSK's Nucala Receives Health Canada's Approval for Severe Eosinophilic Asthma in Children and Adolescents

GSK's Nucala Receives Health Canada's Approval for Severe Eosinophilic Asthma in Children and Adolescents

March 17, 2020

GSK's Nucala (mepolizumab) Receives European Commission Approval for Self-Administration in Severe Eosinophilic Asthma

GSK's Nucala (mepolizumab) Receives European Commission Approval for Self-Administration in Severe Eosinophilic Asthma

August 2, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us